Join | My Account | About Us | Support Us | Contact Us

LATEST:

Membership

About ecancer

Web Site Policy

ecancer are delighted to announce a collaboration with the UK Key Advances in Clinical Practice Series and the British Oncological Association. A series of symposia run in association with King's College London aimed at discussing currently available scientific evidence and expert clinical opinion for the prevention, investigation and management of cancer.

Available to watch now:

Key Advances in the Effective Management of Colorectal Cancer
Key Advances in the Effective Management of Hepatocellular Carcinoma
Key Advances in the Effective Management of Thyroid Cancer
Key Advances in the Effective Management of Head and Neck Cancer

Key Advances in the Effective Management of Colorectal Cancer

This meeting was supported by GE Healthcare. GE Healthcare had no involvement in the agenda or production of the presentations.

Click here to view

Speaker	Subject
Professor Shirley Hodgson	Molecular and Clinical Genetic aspects of Colorectal Cancer
Dr Tamas Hickish	Adjuvant treatment of colorectal cancer: Quantifying the clinical benefits
Dr Gary Middleton	The current status of clinical research using the EGFR monoclonal antibodies in colorectal cancer
Dr John Bridgewater	The hegemony of Bevacizumab?
Professor Dion Morton	Current and planned clinical trials in CRC

Key Advances in the Effective Management of Hepatocellular Carcinoma

This meeting was supported by Bayer Healthcare. Bayer Healthcare had no involvement in the agenda or production of the presentations.

Click here to view

Speaker	Subject
Professor Simon Taylor-Robinson	Epidemiology, aetiology and risk of HCC
Professor Shirley Hodgson	Molecular and clinical genetics of HCC
Professor Phil Robinson	Imaging and Staging
Mr Derek Manas	The evidence base for treatment of HCC <2cm
Professor Nigel Heaton	The evidence base for treatment of HCC 2-8 cm

Key Advances in the Effective Management of Thyroid Cancer

This meeting was supported by GE Healthcare. GE Healthcare had no involvement in the agenda or production of the presentations.

Click here to view

Speaker	Subject
Ms Kate Farnell	Patient and public involvement in clinical decision making and service planning
Dr Sue Clarke	PET scanning: Does it have a role?
Mr Bill Fleming	Surgical Dilemas: The conservative approach
Mr David Scott-Coombes	Complications and long term morbidity
Mr Barney Harrison	Medullary carcinoma: A conservative or aggressive approach?
Dr Musad Haq	20 year follow up of patients treated by low activity 131I ablation
Dr Georgina Gerrard	The national BTA/RCP guidelines: Where are we now?
Dr Ujjal Mallick	The enigma of thyroglobulin +ve/131I-negative patients HiLo: The national UK prospective trial

Key Advances in the Effective Management of Head and Neck Cancer

This meeting was supported by Merck Serono. Merck Serono had no involvement in the agenda or production of the presentations.

Click here to view

Speaker	Subject
Mr Graham Cox	Diagnosis and assessment of lymphadectomy in the neck
Mr Terry Jones	Diet and its role in surgical outcome
Dr Mehmet Sen	Current advances in chemoradiation for locally advanced head and neck cancer
Mr Richard Shaw	Molecular profiling of head and neck cancers - how close are we to predicting the best therapeutic intervention?
Professor Gordon Proctor	Pathophysiology, assessment and potential therapeutic options in radiation-induced xerostomia
Professor Michelle Saunders	Current status of altered fractionation in locally advanced head and neck cancer

We will soon direct the community to forthcoming educational initiatives and programmes to be launched by our Founding Partner, ECCO - the European CanCer Organisation. This will enable us to jointly offer a comprehensive choice of educational materials for surgeons, nurses, physicians, radiation specialists, and technologists, general practitioners, counsellors and advocates of cancer care.